Justin Zelin
Stock Analyst at BTIG
(0)
# 4435
Out of 5,253 analysts
44
Total ratings
25.93%
Success rate
-10.75%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ImmunityBio | Initiates Coverage On: Buy | 6 | 2.98 | 101.34% | 1 | Jan 10, 2025 | |
Enliven Therapeutics | Initiates Coverage On: Buy | 42 | 21.27 | 97.46% | 1 | Dec 13, 2024 | |
CARISMA Therapeutics | Downgrades: Neutral | n/a | n/a | n/a | 2 | Dec 10, 2024 | |
Poseida Therapeutics | Downgrades: Neutral | n/a | n/a | n/a | 2 | Nov 26, 2024 | |
IDEAYA Biosciences | Maintains: Strong Buy | 55 62 | 23.63 | 162.38% | 2 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 90 | 5.64 | 1495.74% | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 2.43 | 393.83% | 1 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 100 125 | 33.54 | 272.69% | 4 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 27 | 5.63 | 379.57% | 1 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1000 800 | 4.37 | 18206.64% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 91 | 32.02 | 184.2% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 10 | 0.89 | 1023.6% | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 16 | 1.61 | 893.79% | 1 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 37 | 9.15 | 304.37% | 2 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 35 | 14.41 | 142.89% | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 90 | 35.91 | 150.63% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 31 | 7.71 | 302.08% | 1 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 16 | 85.29 | -81.83% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 10 | 2.54 | 293.7% | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | n/a | n/a | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 17 | n/a | n/a | 1 | May 18, 2021 |